Bolda-Med, Boldenone Undecylenate, 300 mg/ml, 10 ml

In Stock
55.00€
Discreet package Discreet package
100% Discreet, Private & Plain Stealth Packaging Guaranteed
Secure Payment Secure Payment
100% Secure, Encrypted & Confidential Payment Processing

Boldenone Undecylenate 300 mg/ml by Bioniche Pharma is an extended-release parenteral anabolic formulation featuring a long-acting undecylenate ester. Engineered by Bioniche Pharma to deliver high anabolic potency combined with moderate androgenic activity, Bioniche Pharma Boldenone Undecylenate promotes steady muscular hypertrophy, improves cellular nitrogen conservation, and stimulates erythropoiesis.

CLINICAL PHARMACOLOGY & MECHANISM OF ACTION

Boldenone Undecylenate by Bioniche Pharma functions by binding directly to nuclear androgen receptors across target tissues, driving positive nitrogen balance and accelerating skeletal muscle protein synthesis. Due to its double bond between carbon positions 1 and 2, Bioniche Pharma Boldenone Undecylenate undergoes aromatization at approximately half the rate of native testosterone, minimizing estrogen-related complications while maintaining strong anabolic capacity.

INDICATIONS & CLINICAL USE
  • Therapeutic support in medical conditions requiring long-term lean tissue preservation and recovery from catabolic states using Bioniche Pharma treatment protocols.
  • Adjunctive management for physical rehabilitation following major surgery, chronic illness, or severe trauma under clinical oversight.
CONTRAINDICATIONS
  • Male patients presenting with diagnosed or suspected prostate carcinoma or male breast cancer.
  • Pregnancy, planned pregnancy, and lactation owing to high risks of female fetal virilization and systemic endocrine toxicity.
  • Known hypersensitivity or allergic response to Boldenone Undecylenate, carrier oil vehicles, or inactive compounding excipients in Bioniche Pharma injectables.
PRECAUTIONS & CLINICAL MONITORS
  • Virilization Risk in Females: Female patients receiving Bioniche Pharma Boldenone Undecylenate must be screened regularly for virilizing effects (such as voice deepening, facial/body hirsutism, clitoromegaly, and menstrual irregularities). Discontinuation of therapy is recommended upon initial detection of virilizing signs.
  • Cardiovascular & Lipid Monitoring: Exogenous anabolic agents can adversely shift serum lipid levels by decreasing HDL and raising LDL cholesterol fractions during Bioniche Pharma therapy. Clinical caution is advised for patients with existing coronary artery disease, prior myocardial infarction, or hyperlipidemia, along with periodic serum lipid evaluations.
  • Systemic Observations: Patient monitoring during Bioniche Pharma Boldenone Undecylenate administration should include surveillance for gastrointestinal distress, changes in skin tone, peripheral edema (lower extremity swelling), acne vulgaris, gynecomastia, and mood or behavioral shifts.
ADVERSE REACTIONS
  • Androgenic Effects: Dose-dependent manifestations including acne vulgaris, increased sebum secretion, oily skin, androgenetic alopecia, and shifts in libido associated with Bioniche Pharma administration. Higher doses markedly increase the risk of virilizing features in female patients.
  • Cardiovascular & Hematological: Alterations in serum lipid profiles, mild fluid retention leading to blood pressure elevations, and erythrocytosis (elevated hematocrit), warranting routine complete blood count (CBC) testing during Bioniche Pharma treatment.
DOSAGE & ADMINISTRATION

Boldenone Undecylenate by Bioniche Pharma is formulated strictly for deep intramuscular injection. Regimens should be individually tailored based on diagnostic parameters, gender, and clinical goals:

  • Adult Males: Standard therapeutic protocols for Bioniche Pharma Boldenone Undecylenate typically range from 300 mg to 600 mg weekly, administered as single or split injections under medical direction.
  • Adult Females: Where clinically indicated, therapeutic regimens for Bioniche Pharma Boldenone Undecylenate are generally maintained between 50 mg and 100 mg per week, using conservative dosing to limit virilization risks.
STORAGE & HANDLING

Store Bioniche Pharma Boldenone Undecylenate in a dry, cool location protected from direct sunlight exposure and excessive ambient heat. Do not refrigerate or freeze. Store securely out of the reach and sight of children.